Almost 20% of adult patients affected by B-cell ALL harbor the Philadelphia chromosome translocation Ph1, t(9;22)(q34;q11), which usually differs from CML cases because the BCR/ABL1 gene product has a molecular weight of 190 kDa (p190) (55). This evidence concerns the gene BCR and chronic myelogenous leukemia, BCR-ABL1 positive.